Search
for
Sort by
Research 451–480 of 1000+
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use
- Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
- Fabrication of Thymoquinone and Ascorbic Acid-Loaded Spanlastics Gel for Hyperpigmentation: In Vitro Release, Cytotoxicity, and Skin Permeation Studies
- Multifunctional Hydrogel with Dual Functions of ROS Scavenging and Responsive Antibiotic Release for Synergistic Oral Mucositis Treatment
- Delivery and targeting of nanoparticles into hair follicles
- An overview of current strategies and future prospects in drug repurposing in tuberculosis
- Microneedles-A new paradigm in transdermal delivery of therapeutic agents
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Engineered Hair Follicle Mesenchymal Stem Cells Overexpressing Controlled-Release Insulin Reverse Hyperglycemia in Mice with Type l Diabetes
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- The green healer: an updated review on the phytochemical profile and therapeutic potential of Aloe vera
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- The Role of Janus Kinase Inhibitors in Dermatology
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Review of Cardiovascular Findings in Humans Treated with Minoxidil
- Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions, 1–30 September 2016
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Ultrasound-responsive hydrogel with ROS scavenging and NO controllable release capabilities for accelerated healing of diabetic wounds
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
- Role of skin enzymes in metabolism of topical drugs
- Issues in the Treatment of Epilepsy
- Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth
- JAK inhibitors in dermatology: The promise of a new drug class
- Review of applications of microneedling in dermatology
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery